FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W930698874> ?p ?o ?g. }

• W930698874 endingPage "22351" @default.
• W930698874 startingPage "22338" @default.
• W930698874 abstract "The common γ molecule (γc) is a shared signaling receptor subunit used by six γc-cytokines. These cytokines play crucial roles in the differentiation of the mature immune system and are involved in many human diseases. Moreover, recent studies suggest that multiple γc-cytokines are pathogenically involved in a single disease, thus making the shared γc-molecule a logical target for therapeutic intervention. However, the current therapeutic strategies seem to lack options to treat such cases, partly because of the lack of appropriate neutralizing antibodies recognizing the γc and, more importantly, because of the inherent and practical limitations in the use of monoclonal antibodies. By targeting the binding interface of the γc and cytokines, we successfully designed peptides that not only inhibit multiple γc-cytokines but with a selectable target spectrum. Notably, the lead peptide inhibited three γc-cytokines without affecting the other three or non-γc-cytokines. Biological and mutational analyses of our peptide provide new insights to our current understanding on the structural aspect of the binding of γc-cytokines the γc-molecule. Furthermore, we provide evidence that our peptide, when conjugated to polyethylene glycol to gain stability in vivo, efficiently blocks the action of one of the target cytokines in animal models. Collectively, our technology can be expanded to target various combinations of γc-cytokines and thereby will provide a novel strategy to the current anti-cytokine therapies against immune, inflammatory, and malignant diseases. The common γ molecule (γc) is a shared signaling receptor subunit used by six γc-cytokines. These cytokines play crucial roles in the differentiation of the mature immune system and are involved in many human diseases. Moreover, recent studies suggest that multiple γc-cytokines are pathogenically involved in a single disease, thus making the shared γc-molecule a logical target for therapeutic intervention. However, the current therapeutic strategies seem to lack options to treat such cases, partly because of the lack of appropriate neutralizing antibodies recognizing the γc and, more importantly, because of the inherent and practical limitations in the use of monoclonal antibodies. By targeting the binding interface of the γc and cytokines, we successfully designed peptides that not only inhibit multiple γc-cytokines but with a selectable target spectrum. Notably, the lead peptide inhibited three γc-cytokines without affecting the other three or non-γc-cytokines. Biological and mutational analyses of our peptide provide new insights to our current understanding on the structural aspect of the binding of γc-cytokines the γc-molecule. Furthermore, we provide evidence that our peptide, when conjugated to polyethylene glycol to gain stability in vivo, efficiently blocks the action of one of the target cytokines in animal models. Collectively, our technology can be expanded to target various combinations of γc-cytokines and thereby will provide a novel strategy to the current anti-cytokine therapies against immune, inflammatory, and malignant diseases." @default.
• W930698874 created "2016-06-24" @default.
• W930698874 creator A5001677254 @default.
• W930698874 creator A5022392609 @default.
• W930698874 creator A5024820703 @default.
• W930698874 creator A5025034560 @default.
• W930698874 creator A5037559050 @default.
• W930698874 creator A5043174768 @default.
• W930698874 creator A5051578610 @default.
• W930698874 creator A5055171351 @default.
• W930698874 date "2015-09-01" @default.
• W930698874 modified "2023-09-27" @default.
• W930698874 title "Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum" @default.
• W930698874 cites W1602579358 @default.
• W930698874 cites W1970044643 @default.
• W930698874 cites W1970294718 @default.
• W930698874 cites W1989198317 @default.
• W930698874 cites W1996606664 @default.
• W930698874 cites W2001519848 @default.
• W930698874 cites W2009644403 @default.
• W930698874 cites W2012408584 @default.
• W930698874 cites W2015848791 @default.
• W930698874 cites W2018597572 @default.
• W930698874 cites W2038705787 @default.
• W930698874 cites W2039124116 @default.
• W930698874 cites W2039269176 @default.
• W930698874 cites W2042183983 @default.
• W930698874 cites W2043046650 @default.
• W930698874 cites W2059079830 @default.
• W930698874 cites W2061217789 @default.
• W930698874 cites W2062738834 @default.
• W930698874 cites W2063510122 @default.
• W930698874 cites W2065817253 @default.
• W930698874 cites W2066587571 @default.
• W930698874 cites W2068579383 @default.
• W930698874 cites W2069078105 @default.
• W930698874 cites W2071509055 @default.
• W930698874 cites W2074631079 @default.
• W930698874 cites W2076262930 @default.
• W930698874 cites W2082964839 @default.
• W930698874 cites W2083685529 @default.
• W930698874 cites W2084560238 @default.
• W930698874 cites W2086117528 @default.
• W930698874 cites W2086121828 @default.
• W930698874 cites W2089519221 @default.
• W930698874 cites W2090021858 @default.
• W930698874 cites W2093804554 @default.
• W930698874 cites W2095433065 @default.
• W930698874 cites W2095792567 @default.
• W930698874 cites W2096166085 @default.
• W930698874 cites W2098035977 @default.
• W930698874 cites W2098214917 @default.
• W930698874 cites W2100645101 @default.
• W930698874 cites W2105746459 @default.
• W930698874 cites W2111198391 @default.
• W930698874 cites W2112334818 @default.
• W930698874 cites W2113687173 @default.
• W930698874 cites W2117926449 @default.
• W930698874 cites W2119031997 @default.
• W930698874 cites W2124276056 @default.
• W930698874 cites W2124312546 @default.
• W930698874 cites W2125010485 @default.
• W930698874 cites W2126157889 @default.
• W930698874 cites W2128452798 @default.
• W930698874 cites W2131204388 @default.
• W930698874 cites W2132958485 @default.
• W930698874 cites W2140457183 @default.
• W930698874 cites W2144362290 @default.
• W930698874 cites W2147339230 @default.
• W930698874 cites W2151798187 @default.
• W930698874 cites W2164514428 @default.
• W930698874 cites W2164565066 @default.
• W930698874 cites W2165262559 @default.
• W930698874 cites W2165547934 @default.
• W930698874 cites W2325346815 @default.
• W930698874 cites W2417285827 @default.
• W930698874 cites W4235912108 @default.
• W930698874 cites W4313422318 @default.
• W930698874 doi "https://doi.org/10.1074/jbc.m115.661074" @default.
• W930698874 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4566211" @default.
• W930698874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26183780" @default.
• W930698874 hasPublicationYear "2015" @default.
• W930698874 type Work @default.
• W930698874 sameAs 930698874 @default.
• W930698874 citedByCount "19" @default.
• W930698874 countsByYear W9306988742016 @default.
• W930698874 countsByYear W9306988742017 @default.
• W930698874 countsByYear W9306988742018 @default.
• W930698874 countsByYear W9306988742019 @default.
• W930698874 countsByYear W9306988742020 @default.
• W930698874 countsByYear W9306988742021 @default.
• W930698874 countsByYear W9306988742022 @default.
• W930698874 countsByYear W9306988742023 @default.
• W930698874 crossrefType "journal-article" @default.
• W930698874 hasAuthorship W930698874A5001677254 @default.
• W930698874 hasAuthorship W930698874A5022392609 @default.
• W930698874 hasAuthorship W930698874A5024820703 @default.
• W930698874 hasAuthorship W930698874A5025034560 @default.

• next